Brief: Jubilant Pharmova's Unit Cadista Facility Receives EIR With VAI Status From USFDA
March 12 (Reuters) - Jubilant Pharmova Ltd JUBA.NS: JUBILANT PHARMOVA LTD - JUBILANT CADISTA FACILITY RECEIVES EIR WITH VAI STATUS FROM USFDA JUBILANT PHARMOVA LTD - INSPECTION SUCCESSFULLY CLOSED WITH EIR RECEIPT FROM USFDA Source text: ID:nBSE6bCy94 Further company coverage: JUBA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures